Could Stem Cells Help End the Pandemic?

MARCH 5, 2021


  • Stem cell therapies have advanced in recent years, particularly in the field of regenerative medicine.
  • The COVID-19 pandemic triggered a race for biotechnology and pharmaceutical companies seeking applications for both treatments and a cure.
  • Stem cell therapy has been proposed as a potential treatment for COVID-19 patients with severe symptoms.
  • While COVID-19 vaccine/treatment stocks have been popular, investors should remain mindful of relevant ESG risks associated with proposed stem cell applications.

Download White Paper

Fill out the form to get your free copy via email.
Marketing and Communications Email Opt–in*
Please wait...

Start typing and press Enter to search